國安國際(00143.HK):就有關1億港元可換股債訴訟原吿勝訴
格隆匯 3 月 1日丨國安國際(00143.HK)公吿,債券持有人(作為原吿)針對公司(作為被吿)提出簡易判決申請,以申請(其中包括)登錄針對公司金額為港幣1億元(或替代性地,港幣1億元的損害賠償金)的最終判決。
簡易判決申請的聆訊已於2021年3月1日進行,而香港高等法院原訟法庭判決原吿勝訴,公司須支付總計港幣1億元連同自2020年11月28日至2021年3月1日按最優惠利率另加1%計算的利息以及其後於付款前按判決利率計算的利息。
公司目前正就上述事宜尋求法律意見,並會於適當時候根據上市規則作出公佈,以知會股東及潛在投資者任何重大進展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.